JP Morgan Upgrades Walgreens Boots Alliance to Overweight

JP Morgan analyst Lisa Gill upgrades Walgreens Boots Alliance (NASDAQ:WBA) from Neutral to Overweight.

JP Morgan analyst Lisa Gill upgrades Walgreens Boots Alliance (NASDAQ:WBA) from Neutral to Overweight.

Total
0
Shares
Related Posts
Read More

AstraZeneca Unit Alexion Said Aims to Advance NMOSD Treatment Landscape with Exceptional Ultomiris Efficacy data at ECTRIMS 2022

Alexion, AstraZeneca Rare Disease, will present new data showing significant advances for the treatment of anti-aquaporin-4 (AQP4) antibody-positive (Ab+) neuromyelitis optica spectrum disorder (NMOSD) at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress, 26 to 28 October 2022.

AZN